Kneu Health Secures $5.6M to Scale Next-Generation Neurology Care
Built on one of the world's largest Parkinson's and dementia datasets and adopted across major U.S. health systems and NHS Trusts,...
Neurology
Bausch Health Announces Results of Special Meeting of Shareholders
LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the...
Bausch Health Announces Results of Special Meeting of Shareholders
LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the...
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
– Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension – – New analysis increases overall confidence in the...
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Event to be held October 14th at 4 p.m. ESTBETHESDA, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc....
Italfarmaco Appoints Francesco Di Marco as Chief Executive Officer
MILAN, Italy, October 09, 2025 – Italfarmaco S.p.A. today announced that Dr. Francesco Di Marco has been appointed as Chief...
Theranica Brings First-in-Class, Drug-Free Migraine Care to the Forefront at CNS 2025 with Product Theater and New Real-World Evidence
With a dedicated product theater and new real-world evidence posters, Theranica will spotlight how the Nerivio® REN wearable is reshaping...
Momentum Celebrates Winners of Premier Patient Support Awards: The GoMentum Awards 2025
INDIANAPOLIS, Oct. 8, 2025 /PRNewswire/ -- Momentum Life Sciences announces the winners of the premier Patient Support Awards, known as...
Verana Health Enhances MIPS Advisory Services to Help Medical Practices to Maximize Program Benefits, Reduce Compliance Burden, and Improve Patient Care
Introduction of expanded coaching and advisory services coincides with 2025 American Academy of Ophthalmology Annual Meeting SAN FRANCISCO, Oct. 7,...
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the...
Albert Einstein College of Medicine Awarded $18 Million NIH Grant to Improve Treatment for Serious Mental Illness
New Predictive Platform Will Use Digital Technology and AI to Assist Clinician Decision-Making BRONX, N.Y., Oct. 6, 2025 /PRNewswire/ -- Serious...
Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI
New subscription-based platform empowers a community of Swoop® system users worldwide to access advanced tools in support of imaging research...
NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the XXVII World Congress of Neurology
SANTA ANA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage...
Exicure Highlights Recent Achievements and Near-term Strategic Priorities
Burixafor (GPC-100) Phase 2 Trial in Multiple Myeloma Nears Key Readout Preparing for Expansion into Sickle Cell Disease and Acute...
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy
Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic...
Navitas Life Sciences Named a Major Contender in Everest Group Clinical Data Management Operations PEAK Matrix(R) Assessment 2025
Recognized for innovation in Biostatistics, Clinical Data Management, and Real-World Evidence, powered by AI-driven platforms GAITHERSBURG, MARYLAND / ACCESS Newswire...
Verana Health Introduces Significant Data and Software Enhancements to Support Ophthalmologic Research and Treatment Optimization
Coinciding with 2025 American Academy of Ophthalmology Annual Meeting, the company debuts expanded services and tools for exclusive real-world insights from 85...
Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer
Cambridge, UK, 1 October 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G...
Bausch Health’s Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage® FLX, Clear + Brilliant®, and Fraxel FTX™ offer...
Bausch Health’s Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage® FLX, Clear + Brilliant®, and Fraxel FTX™ offer...